News

Dr. Ming Liu joins ChemPartner as Vice President and Head of Biology and Pharmacology

6月 12, 2018

Shanghai, China (June 12, 2018) – Shanghai ChemPartner today announced the appointment of Ming Liu, Ph.D. as Vice President and the Head of Biology and Pharmacology at the company headquarters in Shanghai, China. Dr. Liu has more than 25 years of experience in drug...

The 2017 Best Life Science Contract Research Organization (CRO), ChemPartner, Chooses CAS SciFinder® to Enable Closer Collaboration with Customers

4月 17, 2018

Columbus, Ohio (April 16, 2018) – CAS, a division of the American Chemical Society (ACS), announced today a multi-year agreement to provide SciFinder to all scientists at ChemPartner, an R&D service provider for the pharmaceutical and biotech industry. ChemPartner...

Shanghai ChemPartner Sponsors Peptide Therapeutic Foundation(PTF)

10月 25, 2017

Shanghai, China (October 25, 2017) – Shanghai ChemPartner today announced their sponsorship of the Peptide Therapeutics Foundation (PTF), a not-for-profit organization established to promote the research and development of peptide therapeutics. ChemPartner, a leading...

ChemPartner Receives 2017 Best Life Science CRO Award from GHP

10月 22, 2017

ChemPartner was named Best Life Science CRO in the 2017 Global Health & Pharma (GHP) Magazine Healthcare & Pharmaceutical Awards. This award is part of the 2017 Healthcare & Pharmaceutical Awards, which recognizes the best-in-class organizations,...

ChemPartner Exhibits at BIOtech Japan 2017

7月 6, 2017

Shanghai, China (July 6th, 2017) – Shanghai ChemPartner recently exhibited at the 16th International Biotech & Life Sciences Exhibition & Conferences on June 28-30 at the Tokyo Big Sight in Japan. BIOtech Japan is Asia’s leading biotechnology and pharma...

Dr. Lilly Xu joins ChemPartner as Vice President and Head of DMPK and Exploratory Toxicology

6月 28, 2017

Shanghai, China (June 28, 2017) – Shanghai ChemPartner today announced the appointment of Lilly Xu, Ph.D. as Vice President and the Head of DMPK and Exploratory Toxicology at the company headquarters in Shanghai, China. Dr. Xu has more than 20 years of experience in...

ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market.

6月 19, 2017

Shanghai, China (June 19, 2017) – ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced...

ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner

3月 24, 2017

Shanghai, China (March 24, 2017) – ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced...